Presentation TCT 2016 Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From Randomized Trials Presenter: A. Michael Lincoff, Franz-Josef Neumann, John A. Bittl October 30, 2016
Presentation TCT 2016 Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion? Presenter: A. Michael Lincoff, Franz-Josef Neumann, Gregg W. Stone October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo October 30, 2016
Presentation TCT 2016 Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI! Presenter: A. Michael Lincoff, Franz-Josef Neumann October 30, 2016
Presentation TCT 2015 Bivalirudin Versus Unfractionated Heparin Analysis: What Is Really Best in Which Patients? Presenter: Carlo Briguori, Roxana Mehran, Carey D. Kimmelstiel October 15, 2015
Presentation TCT 2015 BRAVO 3: A Prospective Randomized Trial of Bivalirudin Versus Heparin in Patients Undergoing Transcatheter Aortic Valve Replacement Presenter: Thierry Lefevre October 15, 2015
Presentation TCT 2015 Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin! Presenter: John A. Bittl, Robert A. Harrington, Michael S. Lee October 12, 2015
Presentation TCT 2015 Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Bivalirudin! Presenter: John A. Bittl, Robert A. Harrington, George D. Dangas October 12, 2015
Presentation TCT 2015 Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results Presenter: John A. Bittl, Robert A. Harrington, Marco Valgimigli October 12, 2015
Presentation TCT 2015 Pharmacology in the Lab: Heparin or Bivalirudin? Presenter: Robert J. Applegate, Ehtisham Mahmud October 11, 2015
Presentation BRIGHT: Bivalirudin vs Heparin With or Without Tirofiban During Primary PCI in Acute MI Presenter: Yaling Han March 23, 2015
Presentation Bivalirudin vs Heparin With or Without GPIs in Patients With STEMI Undergoing Primary PCI Presenter: Gregg W. Stone January 05, 2015
Presentation TCT 2014 Con: Follow the Data and Save the Patient! Presenter: Adrian P. Banning, Gregg W. Stone September 16, 2014
Presentation TCT 2014 Pro: Follow the Data - and Save the Money! Presenter: Adrian P. Banning, Rod H. Stables September 16, 2014
Presentation TCT 2014 Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS Presenter: Timothy Henry September 16, 2014
Presentation TCT 2014 Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention Presenter: Ahmed Rehmani September 16, 2014
Presentation TCT 2014 Heparins Crossover In Percutaneous Coronary Interventions: Is It A Real Issue With Increasing Rate Of Transradial Procedures? Presenter: Stefano Rigattieri September 16, 2014
Presentation TCT 2014 TCT 460: Bivalirudin Versus Heparin During Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials Presenter: John A. Bittl, Tullio Palmerini, Salvatore Cassese, MD September 15, 2014
Presentation TCT 2014 BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention Presenter: Roxana Mehran, Harvey D. White, Yaling Han September 15, 2014